NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
AIkido Pharma Inc (NASDAQ: AIKI)
AIKI Technical Analysis
4
As on 22nd Feb 2023 AIKI STOCK Price closed @ 3.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.59 & Strong Buy for SHORT-TERM with Stoploss of 0.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AIKISTOCK Price
Open | 3.85 | Change | Price | % |
High | 3.88 | 1 Day | -0.11 | -2.81 |
Low | 3.80 | 1 Week | -0.16 | -4.04 |
Close | 3.80 | 1 Month | 0.19 | 5.26 |
Volume | 10734 | 1 Year | 3.03 | 393.51 |
52 Week High 7.21 | 52 Week Low 0.00 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
AIKI Daily Charts |
AIKI Intraday Charts |
Whats New @ Bazaartrend |
AIKI Free Analysis |
|
AIKI Important Levels Intraday
RESISTANCE | 3.95 |
RESISTANCE | 3.90 |
RESISTANCE | 3.87 |
RESISTANCE | 3.84 |
SUPPORT | 3.76 |
SUPPORT | 3.73 |
SUPPORT | 3.70 |
SUPPORT | 3.65 |
AIKI Forecast May 2024
4th UP Forecast | 4.28 |
3rd UP Forecast | 4.13 |
2nd UP Forecast | 4.03 |
1st UP Forecast | 3.94 |
1st DOWN Forecast | 3.66 |
2nd DOWN Forecast | 3.57 |
3rd DOWN Forecast | 3.47 |
4th DOWN Forecast | 3.32 |
AIKI Weekly Forecast
4th UP Forecast | 4.19 |
3rd UP Forecast | 4.06 |
2nd UP Forecast | 3.99 |
1st UP Forecast | 3.91 |
1st DOWN Forecast | 3.69 |
2nd DOWN Forecast | 3.61 |
3rd DOWN Forecast | 3.54 |
4th DOWN Forecast | 3.41 |
AIKI Forecast2024
4th UP Forecast | 17.81 |
3rd UP Forecast | 13.32 |
2nd UP Forecast | 10.54 |
1st UP Forecast | 7.76 |
1st DOWN Forecast | -0.16 |
2nd DOWN Forecast | -2.94 |
3rd DOWN Forecast | -5.72 |
4th DOWN Forecast | -10.21 |
AIkido Pharma Inc ( NASDAQ USA Symbol : AIKI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AIKI Other Details
Segment | EQ | |
Market Capital | 78013592.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
AIKI Address
AIKI Latest News
AIKI Business Profile
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York. Address: One Rockefeller Plaza, New York, NY, United States, 10020
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service